Application of metagenomic next-generation sequencing in patients with infective endocarditis

被引:7
|
作者
Li, Shao-Lin [1 ]
Zhao, Xi [1 ]
Tao, Jun-Zhong [1 ]
Yue, Zhen-Zhen [1 ]
Zhao, Xiao-Yan [1 ]
机构
[1] Zhengzhou Univ, Cardiovasc Ctr, Dept Cardiol, Henan Key Lab Hereditary Cardiovasc Dis,Affiliated, Zhengzhou, Henan, Peoples R China
关键词
metagenomic next-generation sequencing; infective endocarditis; culture-negative; culture-positive; antibiotic regimen; CULTURE-NEGATIVE ENDOCARDITIS; CHALLENGES; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1107170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesMetagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis. MethodsThe present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed. ResultsExcept for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS. ConclusionsCulture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
    Liu, Nana
    Kan, Jianying
    Yu, Naihao
    Cao, Wenbin
    Cao, Jie
    Jiang, Erlie
    Feng, Jing
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5245 - 5254
  • [42] The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU
    Zhao, Junjie
    Sun, Yong
    Tang, Jing
    Guo, Kai
    Wang, Kaiyu
    Zhuge, Jiancheng
    Fang, Honglong
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [43] Application of metagenomic next-generation sequencing in optimizing the diagnosis of ascitic infection in patients with liver cirrhosis
    Shi, Pei
    Liu, Juan
    Liang, An
    Zhu, Wentao
    Fu, Jiwei
    Wu, Xincheng
    Peng, Yuchen
    Yuan, Songsong
    Wu, Xiaoping
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [44] Application of the metagenomic next-generation sequencing in diagnosis and therapy of chronic kidney disease patients with infections
    Liang, Dongrui
    Li, Xiaodong
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (04) : 791 - 792
  • [45] Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients
    Li, Jun
    Zhou, Chao-E.
    Wei, Shan-Chen
    Wang, Li-Na
    Shi, Ming-Wei
    Sun, Chun-Ping
    Lin, Lian-Jun
    Liu, Xin-Min
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [46] Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients
    Peng, Jin-Min
    Du, Bin
    Qin, Han-Yu
    Wang, Qian
    Shi, Yan
    JOURNAL OF INFECTION, 2021, 82 (04) : 22 - 27
  • [47] Potential of metagenomic next-generation sequencing in detecting infections of ICU patients
    Liang, Yanxu
    Feng, Qingguo
    Wei, Kai
    Hou, Xiaoming
    Song, Xiaotao
    Li, Yuantao
    MOLECULAR AND CELLULAR PROBES, 2023, 68
  • [48] Metagenomic next-generation sequencing for pulmonary infections diagnosis in patients with diabetes
    Zhang, Siqin
    Ou, Jing
    Tan, Yuxue
    Yang, Bin
    Wu, Yaoyao
    Liu, Lin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [49] The microbiological diagnostic performance of metagenomic next-generation sequencing in patients with sepsis
    Ren, Di
    Ren, Chao
    Yao, Renqi
    Zhang, Lin
    Liang, Xiaomin
    Li, Guiyun
    Wang, Jiaze
    Meng, Xinke
    Liu, Jia
    Ye, Yu
    Li, Haoli
    Wen, Sha
    Chen, Yanhong
    Zhou, Dan
    He, Xisi
    Li, Xiaohong
    Lai, Kai
    Li, Ying
    Gui, Shuiqing
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [50] Metagenomic Next-Generation Sequencing for the Microbiological Diagnosis of Abdominal Sepsis Patients
    Li, Dongkai
    Gai, Wei
    Zhang, Jiahui
    Cheng, Wei
    Cui, Na
    Wang, Hao
    FRONTIERS IN MICROBIOLOGY, 2022, 13